Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Biol Trace Elem Res 107(3):231
A consensus statement from the Growth Hormone Research Society acknowledges that "preclinical data suggest that GH/IGF-I is involved in cancer development." Angiogenesis Concerns: The VEGF/VEGFR2 pathways activated by BPC-157 and other peptides are "active in roughly half of human cancers." While promoting blood vessel formation is beneficial for healing, it's concerning in the context of potential tumor growth
Feb 3, 2026 Tired of conflicting information about peptides for weight loss during menopause
Targets visceral fat loss, activates fat breakdown, reduces stubborn fat areas Tesamorelin / Ipamorelin Visceral Vanisher Tesamorelin is FDA-approved to reduce visceral abdominal fat & stimulates natural GH release
Recommended storage conditions: Long-term archival storage: 20C in a sealed, desiccated, light-protected environment
US$ 23.80
US$ 28.77
US$ 24.03
US$ 21.06
US$ 21.09
US$ 26.90
US$ 23.67
US$ 26.27
US$ 24.45
US$ 26.71
US$ 29.48
